secwatch.observer — SEC 8-K summary
======================================

Issuer:     Connect Biopharma Holdings Ltd (CNTB)
CIK:        0001835268
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001835268-25-000044
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Connect Biopharma terminates ADR program; ordinary shares to list directly on Nasdaq under CNTB
--------------------------------------------------------------------------------

- On July 18, 2025, ordered termination of Deposit Agreement with Deutsche Bank Trust Company Americas.
- ADR program and Deposit Agreement expected to terminate on or about September 2, 2025.
- Each ADS (1 ordinary share) will be mandatorily cancelled and exchanged for ordinary shares 1:1.
- Company plans to list ordinary shares directly on Nasdaq under symbol CNTB after ADR termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835268/000183526825000044/0001835268-25-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835268/000183526825000044/cntb-20250718.htm
  HTML page:      https://secwatch.observer/filing/0001835268-25-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer